08-November-2022
Written by Renáta Vincze
’Catalysts to patient access and pricing success for better public health – worldwide.’ This is our motto. Based on Renáta Vincze’s writing, we see how important catalysts can be.
Personal Reminiscence
The different types of Chemistry during my Pharmacy studies have proven the importance of a catalyst in the chemical reactions.
What I realized only a few years later is that catalysts are not only those organic or inorganic compounds that enable a chemical reaction – people can fulfill this role as well in different areas, as an individual or as a team. This role can bring value in our own life, in other people’s lives, in our relationships, business, etc.
On a mission to create win-win
Akceso Advisors’ main purpose is to facilitate the market access of different treatments all around the world, enabling win-win situations for the stakeholders: patient, manufacturer, marketing authorization holder and payer.
For example applying Akceso’s Real Options Based Optimisation approach, the patients in the countries get rapid access to the treatment while the pharma company benefits by optimal application of International Reference Pricing rules.
- Akceso’s Accelerated Access Initiative,
- International Reference Pricing,
- Launch sequence optimisation and
- Shaping pharma pricing policies
are only a few pieces of this complex equation.
Mechanism of action
There is one essential difference between Akceso working as a catalyst and the chemical ones, namely the mode of action. A literal catalyst is meant to increase the rate of the process without itself undergoing any permanent change. However, we in Akceso are in continuous change and we evolve as we take on and deliver each of our internal and external projects. Every member of our multicultural team adds knowledge to the project but also enriches themselves through the process and the people involved.
Why are these interactions beneficial and why does the world need catalysts?
Because we all need changes to the better, both from professional and personal perspective. In order to maintain or increase progress and productivity, we can become each other’s mentor – even without realizing it. This happens in our team between colleagues, but also in client interactions. I’m sure this is an important internal motivation in many companies, and challenging each other in a positive way will certainly lead to better results. Do you challenge each other in your organization?
In Akceso it has been proven several times that 1+1 can become 3 or even more if we achieve it together. This ability is important in order to obtain the best possible results; something that we are committed to, especially in a complex project like a pricing potential assessment or a reimbursement strategy for a medicine.
It allows us to successfully deliver pharma pricing and market access projects from A to Z, from end to end.
I am glad to be part of this journey as an Akceso member – like Akceso’s motto says, by being ‘CATALYSTS TO PATIENT ACCESS AND PRICING SUCCESS FOR BETTER PUBLIC HEALTH – WORLDWIDE.’
Photos: https://www.canva.com/
Read the recent posts in our blog
April 2nd Tariffs Proclamation Increases Pressure on US Pharma Imports
On April 2, 2026, President Trump imposed 100% tariffs under Section 232 on patented pharmaceuticals and APIs. Exemptions for generics, MFN agreements, and onshoring. Impact on US imports analysed.
Faces Behind the Tools: Dávid and Szabolcs, Akceso’s Newest Techie Pillars for IRP and MFN Excellence
We are happy to introduce Dávid and Szabolcs, the two newest members of our Techie team, both joined recently in 2025.
Akceso Advisors elects Dr. Seng Chin Mah as Board Member
Akceso Advisors AG, a leading independent global advisory firm specializing in market access, pricing, reimbursement strategy, operations and policy-setting for life-science companies and authorities, announced today the election of Dr. Seng Chin Mah as a new non‑executive member of its Board of Directors.
Mind the communication gap in patient access
Read the story of how the clear communication unlocked the market access potential of an innovative product for our client.
